Navigation Links
Flu Widespread in U.S., but Vaccine Is Poor Match
Date:2/15/2008

Even though shot misses 2 strains found, health officials still recommend inoculation

FRIDAY, Feb. 15 (HealthDay News) -- Widespread flu activity now exists in virtually every state, and many of the infections are being caused by some strains not covered by this year's influenza vaccine, U.S. health officials said Friday.

"After relatively low levels of influenza activity in the early part of the season, since January, influenza activity has been picking up in the nation," Dr. Joe Bresee, chief of the branch of epidemiology and prevention at the U.S. Centers for Disease Control and Prevention's Influenza Division, said during a teleconference.

"This season, we are seeing more disease out there and higher rates of hospitalizations and deaths than we've seen in the last couple of years," Bresee added.

Much of the increased activity owes to the fact that this year's flu vaccine isn't a match for some of the strains currently circulating in the United States, and some strains are becoming resistant to a common antiviral medication. The CDC reported last week that this year's flu vaccine doesn't match two of the three strains of influenza circulating in the United States.

"Slightly more than half of the viruses that we are looking at in our lab are viruses that are different than the vaccine strain," Bresee said. "So, they may not be well covered by the vaccine."

The virus strain most common in the United States right now is the influenza A H3N2 strain, and it's one strain not included in this year's vaccine. Also, this year's vaccine is not well matched against influenza type B, Bresee said.

The World Health Organization announced Thursday its recommendation for next year's flu vaccine, and it includes vaccine against the H3N2 strain and other strains not in this year's vaccine, Bresee said.

Complicating matters, some of this year's influenza type A virus is showing resistance t
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
2. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
3. Study finds widespread vitamin and mineral use among cancer survivors
4. Report Finds Widespread Steroid Use in Baseball
5. Survey Reveals Widespread Lack of Communication With Doctors About Memory Concerns
6. Drug-Resistant Staph a Widespread Threat
7. Human rights violations widespread in eastern Burma
8. Discovery of widespread tumor growth gene holds promise for effective anti-cancer treatment
9. AAP Initiates Public Relations Effort to Counter Bad Vaccine Publicity
10. Vaccine for stomach flu may be possible, UNC research shows
11. Vaccine Could Cut Bouts With Stomach Flu
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Flu Widespread in U.S.,  but Vaccine Is Poor Match
Flu Widespread in U.S., but Vaccine Is Poor Match
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 1Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 2Research Reveals How Mitochondrial Gene Defects Impair Respiration Other Major Life Functions 58280 3Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 1Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 2Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 3Encouraging HIV AIDS Vaccine Trial Results Support GeoVax Labs Inc Strategy 14265 4Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 1Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 2Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 3Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 4Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 5Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 6Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 7Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 8Reportlinker Adds In Vitro Diagnostics in a Recession 3A IVD Market Forecasts Analysis and Success Strategies Report 14260 9